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Onconase (ONC), a member of the RNase A superfam-
ily extracted from oocytes of Rana pipiens, is an effec-
tive cancer killer. It is currently used in treatment of
various forms of cancer. ONC antitumor properties de-
pend on its ribonucleolytic activity that is low in com-
parison with other members of the superfamily. The
most damaging side effect from Onconase treatment is
renal toxicity, which seems to be caused by the unusual
stability of the enzyme. Therefore, mutants with re-
duced thermal stability and/or increased catalytic activ-
ity may have significant implications for human cancer
chemotherapy. In this context, we have determined the
crystal structures of two Onconase mutants (M23L-ONC
and C87S,des103–104-ONC) and performed molecular
dynamic simulations of ONC and C87S,des103–104-ONC
with the aim of explaining on structural grounds the
modifications of the activity and thermal stability of the
mutants. The results also provide the molecular bases to
explain the lower catalytic activity of Onconase com-
pared with RNase A and the unusually high thermal
stability of the amphibian enzyme.
Ribonucleases are widely found in living organisms and have
been proposed to function in RNAmetabolism and gene expres-
sion (1). Several ribonucleases have been isolated from organs
of various animals and have been well characterized. Bovine
pancreatic ribonuclease (RNase A)1 is the most studied mem-
ber of the family (2). It has been used as a model for the study
of the fundamental aspects of protein structure and function (2,
3). Several members of the RNase A superfamily exhibit addi-
tional biological functions in connection with their intrinsic
ribonucleolytic activities (4, 5). In humans, eosinophil-derived
neurotoxin and eosinophil cationic protein (6) exert neurotox-
icity as well as antiparasitic activity (7). Bovine seminal ribo-
nuclease (BS-RNase) has been found to induce apoptosis of
human thyroid carcinoma cell lines (8, 9). Onconase (ONC)
from Rana pipiens is cytotoxic (10) and cytostatic to several
tumor lines and is currently in phase III clinical trials for the
treatment of malignant mesothelioma (8, 11, 12).
ONC shares 30% of identity with the sequence of RNase A,
and its three-dimensional structure exhibits a highly con-
served ribonuclease-like topology (13), which comprises a
characteristic V-shaped -sheet motif surrounded by three
-helices. Differences are mainly localized in the loop regions,
which are significantly shorter in ONC, and at the C termi-
nus where a disulfide bond, unique to amphibian ribonucle-
ases, tethers the C-terminal residue Cys104 to Cys87 located
in one strand of the -sheet (13). Another distinct property of
ONC is the presence of an N-terminal pyroglutamate (Pyr1),
which folds back against the N-terminal helix (13). The over-
all active site architecture closely resembles that of RNase A
and includes His10, Lys31, and His97, which form the catalytic
triad corresponding to His12, Lys41, and His119, respectively,
of the pancreatic enzyme. Despite this similarity and the
activating effect of the N-terminal Pyr residue (14), the On-
conase activity is by 3–5 orders of magnitude lower in com-
parison with RNase A, depending on the used substrate (15).
The structural reasons for this very low ribonucleolytic ac-
tivity are not yet clearly understood.
Although very low, the activity is essential for the Onconase
antitumor action (7), which seems to be related to its ability to
evade the ribonuclease inhibitor (10), a protein present in hu-
man cells that protects them from the potentially damaging
effects of their own RNases. Although ONC is a frog protein, it
is immunologically tolerated by humans. It only causes a re-
versible renal toxicity (16), probably linked to the enzyme sta-
bility, which is unusually high for a protein isolated from a
mesophilic source (17). ONC has a denaturation temperature
(Td) close to 90 °C at pH 6.0 and is particularly resistant to
proteolysis (17).
To improve the performance of the protein as an antitumor
agent, ONC mutants have been prepared. These mutants were
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proved to have a reduced thermal stability and/or increased
catalytic activity (17–19). In particular, the mutant in which
methionine 23 has been replaced by leucine (M23L-ONC) is
5-fold more active than the native enzyme and fully toxic to-
ward tumor cells (17). On the other hand, mutants in which the
disulfide bond Cys87-Cys104 has been eliminated,
(C87S,des104)-ONC and (C87S,des103–104)-ONC, exhibit a
greatly reduced thermal stability with a Td of 70.2 and 69.3 °C,
respectively (19), whereas their catalytic action and antitumor
activity are practically unaffected.
Here we report the crystal structures of (C87S,des103–104)-
ONC and M23L-ONC and molecular dynamic (MD) simula-
tions of ONC and (C87S,des103–104)-ONC. The results provide
strong evidence of the high rigidity of the enzyme. In particu-
lar, despite the strict similarity in the -sheet architecture,
ONC does not possess the -sheet breathing motion character-
istic of RNase A and considered to be functionally important
(20–22). The decreased flexibility provides a basis to explain
the low affinity of ONC toward nucleotides (23) and, more
generally, its lower catalytic activity. It also provides a basis to
rationalize the substitution effects on the activity and thermal
stability of the mutants.
EXPERIMENTAL PROCEDURES
Crystallization and Data Collection—Mutants of Onconase were ex-
pressed in Escherichia coli and purified as described previously (17–19).
Crystallization was achieved by the sitting-drop vapor-diffusion tech-
nique at 277 and 293 K for (C87S,des103–104)-ONC and M23L-ONC,
respectively. A volume of 2 l of protein at 15 mg/ml was mixed with an
equal amount of the reservoir solution containing 0.1 M sodium acetate,
pH 4.5–4.7, 0.2 M lithium sulfate, and 25–27% (w/v) polyethylene glycol
8000. Crystals of the two mutants grow in 2–4 days; they are nearly
isomorphous and belong to the orthorhombic space group P212121. Dif-
fraction data were collected at room temperature on a ENRAF-NON-
IUS DIP area detector equipped with an FR591 rotating anode of the
Istituto di Biostrutture e Bioimmagini (Consiglio Nazionale delle
Ricerche, Naples, Italy). For M23L-ONC, diffraction data were collected
also at 100 K on the x-ray diffraction beamline at Elettra Synchrotron,
Trieste, Italy. Trehalose (300 mg/ml) was used as cryoprotectant. All
data were processed using DENZO and SCALEPACK (24). Crystal
parameters and data collection statistics are presented in Table I.
Refinement—The crystal structure of the twomutants was obtained by
the nearly isomorphous wild type structure solved by Mosimann and
co-workers (13) at 1.7-Å resolution. The refinement was carried out with
the programCNS (25). Several alternating cycles of positional refinement,
energy minimization, individual temperature factor refinement, and
manual model building were performed. Water molecules were inserted
into the model at positions corresponding to peaks in the Fo  Fc electron
density map with heights greater than 3 and at hydrogen bonding
distances from appropriate atoms. Sulfate anions were also located in
difference Fourier maps and added to the current models. The program
PROCHECK (26) was used to analyze the quality of the final structures.
The refinement statistics are presented in Table II. The figures were
drawn using MOLSCRIPT (27) and BOBSCRIPT (28).
Molecular Dynamic Simulations—All MD simulations were per-
formed with GROMACS program (29) using a procedure successfully
used for other members of pancreatic-like superfamily (22, 30, 31).
Briefly the x-ray structures were immersed in cubic boxes containing
more than 6700 water molecules. The ionization state was set to mimic
a neutral pH environment. The overall charge of the systems was
neutralized by adding the appropriate number of ions more than 7 Å
away from the protein surface. The solvent was relaxed by energy
minimization followed by a 20-ps MD simulation at 300 K. The overall
system was then minimized without restraints before the productive
run. All bond lengths were constrained by LINCS (32); Newton’s equa-
tions of motion were integrated with a time step of 2 fs, and atomic
coordinates were saved for analyses every 0.5 ps. A dielectric constant
of 1 was used. The simulated temperatures, 300 and 350 K, were kept
constant by coupling the system to an external bath (33). A cut-off of 14
Å was used for the treatment of both electrostatic and Lennard-Jones
interactions. 4-ns simulations were performed at 300 and 350 K for
ONC and for the mutant (C87S,des103–104)-ONC. A second independ-
ent 10-ns simulation of ONC was carried out at 300 K using the same
parameters of 4-ns simulation but a different set of initial velocities. A
brief summary of the simulation procedure is reported in Table III.
Analysis of the MD Trajectories—The global structural stability of
the simulations has been evaluated by following several geometric
parameters as a function of time. The ONC and (C87S,des103–104)-
ONC simulations were stable and exhibited great similarity to the x-ray
starting structures at 300 K. The root mean square deviation (r.m.s.d.)
values for the C atoms are on average 2.2 Å, and the average values for
radius of gyration and solvent-accessible surface area are comparable
with those experimentally observed. At 350 K, the r.m.s.d. values are
2.2 Å for ONC and 3.2 Å for (C87S,des103–104)-ONC. The mobility of
each C atom with respect to the average structure (root mean square
fluctuation) has been calculated according to Equation 1,
1N 
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n
ri r2 (Eq. 1)
where ri represents the element position at time i, and r represents the
average value.
Essential degrees of freedom were extracted from the equilibrated
portions of the trajectories according to the essential dynamic method
(34). The eigenvectors corresponding to the higher 10 eigenvalues ob-
tained from diagonalization of the covariance matrix of C atom fluc-
tuations were used to describe almost all the conformational substates
accessible to the protein (essential subspace). To evaluate the overlap of
the conformation spaces spanned by the different systems, we have
calculated the root mean square inner product (RMSIP) (22, 35–37).
The RMSIP is defined according to Equation 2,
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where i and j are the ith and jth eigenvectors from the two trajecto-
ries, respectively. The RMSIP value was also used to ascertain the
convergence in the essential subspace between two halves of the equil-
ibrated portion of the trajectories and to evaluate their similarity.
RESULTS AND DISCUSSION
X-ray Structure of M23L-ONC and (C87S,des103–104)-
ONC—The room temperature structure of M23L-ONC was re-
TABLE I
Crystal parameters and data collection statistics
Values in parentheses correspond to the highest resolution shells (1.94–1.90, 1.82–1.78, and 1.54–1.51 Å for (C87S,des103–104)-ONC and room
temperature and 100 K temperature structures of M23L-ONC, respectively).
(C87S,des103–104)-ONC M23L-ONC M23L-ONC
T (K) 298 298 100
Space group P212121 P212121 P212121
a (Å) 32.51 32.54 32.29
b (Å) 41.26 40.88 38.54
c (Å) 69.60 69.41 69.08
Resolution limits (Å) 20.00–1.90 20.00–1.78 20.00–1.51
No. of observations 43,004 46,120 181,712
No. of unique reflections 7,322 8,880 14,146
Completeness (%) 93.5 (92.8) 94.8 (87.2) 99.8 (99.9)
I/(I) 19 (8) 23 (8) 54 (26)
R-merge (%) 6.6 (17.7) 8.0 (18.9) 3.5 (6.6)
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fined to an R-factor of 0.168 (R-free  0.212) using data col-
lected at 1.78-Å resolution and includes 90 water molecules and
one sulfate anion. A low temperature model was also obtained
by using the 1.51-Å resolution data, collected at 100 K, and
refined to a final R-factor of 0.156 (R-free  0.198); in this case
144 water molecules and three sulfate anions were included in
the final model. The room temperature crystal structure of
(C87S,des103–104)-ONC, refined at 1.90-Å resolution to a final
R-factor of 0.144 (R-free  0.194), includes 99 water molecules
and one sulfate anion. The average B-factors for all the non-
hydrogen atoms are 17.5, 11.2, and 19.9 Å2 for the three struc-
tures, respectively. A full list of the refinement statistics is
reported in Table II. Fig. 1 gives a general view of the molecule;
the mutated and/or deleted residues are shaded.
The overall structures of the two mutants, refined with the
room temperature data, are very close to that of the wild type
enzyme (13), showing that in both cases the mutations do not
produce any relevant alteration of the protein tertiary struc-
ture. Indeed, after superimposition of each mutant on the na-
tive protein, the r.m.s.d. of all the backbone atoms (N, C, C,
and O) is 0.16 Å for M23L-ONC and 0.13 Å for (C87S,des103–
104)-ONC. Slightly higher values were obtained when the 100
K structure of M23L-ONC was compared with the room tem-
perature structure (0.31 Å) or with the wild type enzyme (0.38
Å). The former value is very close to the one obtained when two
crystal structures of RNase A, refined at 98 and 300 K, respec-
tively, are compared (38).
The close similarity of the two mutants with the wild type
enzyme also extends to the active site region where a sulfate
anion is located. This anion, which mimics the phosphate of the
natural substrate, hydrogen bonds His10 and His97 as found in
the structure of the wild type enzyme (13) as well as in several
other members of the pancreatic-like superfamily (39–43). In
the mutants, as well as in the wild type structure, His97 adopts
a g conformation (1  76  3°) very similar to the B
conformation of the corresponding His119 in RNase A (44). In
this enzyme, His119 has access to more than one conformation,
although the A conformation (1 close to 180°), which is con-
sidered to be catalytically relevant in the transphosphorolytic
step, is more often encountered due to the stabilizing interac-
tion with the carboxylate group of Asp121 (40). In the corre-
sponding position 99 of Onconase, the presence of a valine
FIG. 1. A ribbon diagram showing the secondary structural
elements in M23L-ONC. The side chains of Pyr1 and Leu23, the
C-terminal disulfide bridge (Cys87-Cys104), and the active site sulfate
ion are drawn in ball-and-stick representation.
TABLE II
Refinement statistics
(C87S,des103–104)-ONC M23L-ONC M23L-ONC
Resolution range (Å) 20.0–1.90 20–1.78 20–1.51
Number of reflections (F 	 2(F)) 6,841 8,167 14,085
R-factor/R-free (%) 14.4/19.4 16.8/21.2 15.6/19.8
Number of protein atoms 867a 831a 826
Water sites 99 90 144
Sulfate anions 1 1 3
r.m.s.d. from stereochemical target values
Bond length (Å) 0.032 0.007 0.034
Bond angles (°) 2.30 1.53 2.71
Dihedral angles (°) 25.1 24.9 25.3
Improper angles(°) 1.59 0.87 2.08
Average B-factor (Å2)
Protein, overall 19.9 17.5 11.2
Main chain 15.6 13.8 7.6
Side chain 20.3 18.4 11.3
Ion atoms 32.0 29.1 24.4
Solvent atoms 36.0 30.2 20.1
a The different number of atoms is due to the presence of multiple side chain conformations.
TABLE III
Summary of the MD runs
ONC (C87S,des103–104)-ONC
Software used GROMACS GROMACS
Starting model (Protein Data Bank code) 1ONC Present structure
Time (ps) 4,000a 4,000
Total number of atoms 20,958 20,896
Number of water molecules 6,732 6,744
Box volume (nm3) 216 216
Electrostatic interaction treatment Cut-off truncation method Cut-off truncation method
Cut-off for Coulombic interactions (Å) 14 14
Cut-off for Lennard-Jones interactions (Å) 14 14
Integration time step (ps) 0.002 0.002
Constraints LINCS algorithm LINCS algorithm
Temperature (K) 300 and 350 300 and 350
a A second independent 10-ns simulation of ONC was carried out at 300 K using the same parameters of 4-ns simulation but a different set of
initial velocities.
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instead of the aspartate decreases the A conformation stability
because of the loss of the salt bridge and the greater steric
hindrance of the side chain. This feature is expected to reduce
the activity of the enzyme at most in the first step of the
enzymatic reaction and cannot account for the dramatic de-
crease observed for the first as well as for the second rate-
limiting hydrolytic step (15). In this context, the explanation of
the increased activity of M23L-ONC in comparison with the
wild type enzyme on the basis of their structural differences
may shed light on the origin of the very low ribonucleolytic
activity of Onconase.
In the room temperature model of M23L-ONC, despite its
similarity with the wild type enzyme, small conformational
changes of residues near the mutation site and in the active
site are indeed observed. The side chain of the mutated residue
is located in a hydrophobic cavity lined by the side chains of
Ile22, Phe28, Phe36, Tyr77, Cys68, and Lys31 and stiffened by the
presence of the three aromatic residues (Fig. 2A). The greater
bulkiness of the Leu branched side chain compared with Met
produces a small but significant rearrangement of the contact-
ing residues such as Phe36 and, particularly, Lys31, a residue
that plays an important role in the ribonucleolytic activity of
the enzyme (23). As a consequence, the N of this lysine mod-
ifies its hydrogen bonding network. Both in ONC and in
(C87S,des103–104)-ONC, the cationic head of Lys31 is hydro-
gen-bonded at a distance of 2.9 and 3.2 Å, respectively, to the
carbonyl oxygen of Lys33. In M23L-ONC, Nmoves about 0.5 Å
away from this oxygen in the direction of the sulfate and
establishes an hydrogen bond to O	-1 of Asn34 at a distance of
3.0 Å (4.0 Å in ONC and 3.7 Å in (C87S,des103–104)-ONC) (Fig.
2B). Although small, this movement places the side chain in a
more favorable position to activate the enzymatic reaction.
Incidentally a similar hydrogen bond was found in RNase A
between the conserved active site residues Lys41 and Asn44
(41). The features observed in the room temperature structure
of M23L-ONC were fully confirmed by the 100 K structure
refined at a resolution of 1.5 Å. Despite some differences aris-
ing from the binding of two extra sulfate anions and the rear-
rangement of a few exposed side chains, the lysine is practically
unmoved and well defined in the electron density map together
with its hydration sphere. In this case, in addition to the
hydrogen bond to O-	1 of Asn34 (3.2 Å), N is bonded to two
water molecules in a roughly tetrahedral fashion, whereas its
distance from the oxygen of Lys33 is 3.7 Å (Fig. 2C).
A reorientation of the lysine side chain in comparison with
the wild type enzyme has been recently detected in a NMR
study of a variant of ONC, which, in addition to the replace-
ment of Met23 with Leu, presents at the N terminus the sub-
stitution of Pyr1 with the sequence Met-Gln (45). It is gratifying
to notice that both solid state and solution data converge in the
indication that the leucine side chain perturbs the lysine native
conformation, thus strengthening the indication that this is a
genuine feature of the mutant. A similar subtle modification of
the side chain conformation of the catalytic Lys41 was observed
in RNase A and was suggested to be important in the substrate
binding (41) and in the pH modulation of the enzyme activity
(40, 46). In the same enzyme a very subtle shift of the active
site His119 was considered to affect the catalytic activity of
some mutants of the pancreatic enzyme (47).
The elevated stiffness of the Onconase structure can be more
deeply appreciated in light of the (C87S,des103–104)-ONC
structure. In this mutant, not only the active site region but
also the C terminus, despite the lack of the last two residues
and of the terminal disulfide bridge, is extremely close to the
wild type enzyme (Fig. 3) at a point that the overall r.m.s.d. on
backbone atoms is only 0.13 Å. In particular, as reported above,
Lys31 shares with the wild type enzyme the hydrogen bonding
network and its conformation is closer to ONC rather than to
M23L-ONC. These findings are in line with the experimental
result that (C87S,des103–104)-ONC and ONC have compara-
ble catalytic activity (19). Moreover the structural data also
demonstrate that the geometrical requirements for the forma-
tion of the disulfide bridge Cys87-Cys104 are fully satisfied by
the minimum energy conformation reached in the absence of
the covalent constraint. This result is not highly surprising as
there are several examples of disulfide-deficient variants of
proteins that display only small structural variations compared
with the wild type enzyme (48–54). Nevertheless the perfect
match of the two strands in the absence of the disulfide can be
taken as an indication that the disulfide bridge has been im-
plemented in the Onconase software at the very end of the
evolutionary pathway of the molecule when its three-dimen-
sional pattern had already been fully defined. This is also in
line with the fact that the C-terminal disulfide bridge is not
conserved along the RNase A superfamily and appears rather
recently in the phylogenetic pathway (55).
In addition to the sulfate in the active site, two more sulfates
are located on the surface of the mutant M23L-ONC at 100 K
where they are stabilized by intermolecular contacts. In par-
ticular SO4
701 forms a hydrogen bond with the N
 atom of the
Trp3 and interacts with the N atom of Lys45 and with three
water molecules, two of which interact also with SO4
901. SO4
901
is located in a cavity lined by residues 40–42, where the largest
variations are observed with respect to the native and room
temperature structure, and forms hydrogen bonds with the
side chain of Arg40 and with the main chain nitrogen of Gln42.
The two sulfates are 6.75 Å apart, and their relative position
gains further stabilization by the proximity of the Lys8 side
FIG. 2. A, hydrophobic cavity surrounding the Leu23 side chain whose omit Fo  Fc map is contoured at 2(I). B, superimposition of the active
site region of (C87S,des103–104)-ONC and M23L-ONC (cyan) at room temperature. The side chain of Lys33 was not drawn. C, active site
architecture in the M23L-ONC structure at 100 K. Hydrogen bonds are represented by dotted lines. Wat, water.
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chain of a symmetry-related molecule. Notably the Trp3 is
conserved among the frog ribonucleases, whereas Lys45 and
residues 40–42 are not. However, the positions of these sulfate
anions are considerably different from those of the putative
secondary interaction sites, as detected in pancreatic-like ribo-
nucleases (56, 57), and presumably do not have any significant
functional role.
MD Simulations of ONC—Enzymatic properties of RNase A
have been suggested to be directly correlated to the dynamics of
the protein (21, 58) and in particular to a subtle but well
documented breathing motion of the -sheet motif (21). More-
over the low frequency motion can be evidenced by means of
molecular dynamic calculations as shown by the results on
RNase A (20), on its swapped dimeric forms (30, 31), and on
Angiogenin (22), another member of the RNase superfamily.
We have now extended the MD simulations to ONC. The
results show that the dynamic behavior of ONC is considerably
different from that observed for other RNases. The root mean
square fluctuations of C atoms are reported in Fig. 4 in com-
parison with those of RNase A. With the exception of residues
25–28, both regular secondary structure regions (root mean
square fluctuation,

1 Å) and loop residues (root mean square
fluctuation, 
1.7 Å) show lower mobility during the simulation
than the structurally aligned residues of RNase A or Angioge-
nin (data not shown). Moreover none of the first eigenvectors
obtained by essential dynamics are suggestive of a collective
motion that would resemble the -sheet motion discussed
above. In all previous cases the molecular breathing motion
could be detected as one of the highest eigenvectors extracted
by 3- or 4-ns trajectories. Nevertheless we have repeated and
extended the ONC simulation up to 10 ns with results that
match well those obtained in the shorter simulation. Indeed the
essential subspaces sampled by ONC in the two trajectories are
highly overlapped as indicated by the high value (0.73) of the
RMSIP (see “Experimental Procedures” for details). Given the
similarity in the results of the two simulations and for sake of
homogeneity with the other simulations, only the 4-ns results
will be considered further.
The trace of covariance matrix of 0.62 nm2, calculated in the
last 2 ns of the ONC trajectory, is significantly smaller than
that calculated from the RNase A simulation (1.30 nm2) and is
comparable to that observed, for instance, for the hyperther-
mophilic enzymes Sso7d (59) and for rubredoxin from Pyrococ-
cus furiosus (60) at room temperature. The elevated rigidity of
ONC that emerges from the MD calculations is in a good
agreement with the NMR data on the E1S mutant of ONC
published by Gorbatyuk et al. (45). Their model free analysis of
the backbone amide nuclear Overhauser effect relaxation data
shows that this molecule exhibits an extremely limited flexi-
bility on the ps/ns time scale with a mean value for the gener-
alized order parameter of 0.94  0.04 and that the active site
residues display no distinctive backbone flexibility.
The dynamic features of ONC are of particular interest in
relation to the geometry of the active site as it emerges from the
published structure of the native enzyme (13) and that of the
two mutants presented in this study. The separate superimpo-
FIG. 3. C-terminal region of (C87S,des103–104)-ONC (dark
gray) and ONC (light gray; Protein Data Bank code 1ONC) after
superimposition. Two water (Wat) molecules take the place of Ser103
and Cys104 in (C87S,des103–104)-ONC. The omit Fo  Fc map for Ser
87
is contoured at 2(I).
FIG. 4. Root mean square (RMS) fluctuations of C atoms in
the equilibrated region of the trajectory for ONC (Œ) and RNase
A (●). Results of 4-ns molecular dynamic simulation at 300 K are
shown.
FIG. 5. A, C atom tracing of ONC structure (dark gray) compared
with that of RNase A (light gray; Protein Data Bank code 1KF2). B,
superimposition of the complex of RNase A with dCpdA (light gray;
Protein Data Bank code 1RPG) to ONC (dark gray; Protein Data Bank
code 1ONC). In both cases the V1 arm (see text for the definition) was
used for the superimposition of the two proteins. Hydrogen bonds are
represented by dotted lines.
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sition of the N, C, C, and O atoms of the two arms V1 (residues
55–58, 86–91, and 96–101) and V2 (residues 33–38, 63–70, and
77–84) of ONC -sheet on the corresponding regions of RNase
A, BS-RNase, and other RNases shows that in comparison the
active site cleft between the two arms of the amphibian enzyme
-sheet is significantly wider (Fig. 5A). For a more quantitative
estimate we have evaluated the distance between the nitrogen
amide atoms of Thr45 and Phe120, two conservative residues
placed on the two arms of the -sheet, which contribute with
two key hydrogen bonds to the stability of the bound substrate
in the active site of RNase A (56, 61) and BS-RNase (62, 63).
Due to the breathing motion, this distance in the latter proteins
depends on several variables, such as crystal packing, crystal-
lization solution, pH, ligands bound to the active site, etc. From
a survey of more than 40 RNase A and BS-RNase models in the
Protein Data Bank (64), it emerges that the distance spans
the interval 7.5–8.5 Å with a mean value of about 8.0 Å. In the
Onconase structures the distance between the nitrogen amide
atoms of the corresponding residues Thr35 and Phe98 is sharply
restricted to a value close to 9.1 Å. Albeit in the last case the
sample is greatly reduced, the distance is significantly larger
than the largest value found for the pancreatic and seminal
enzymes. As a result, the residues important for catalysis and
for the binding of the substrate, such as Lys31 and Thr35 on the
V2 arm and His
97 and Phe98 on the V1 arm are about 1 Å
further apart in comparison with the corresponding residues of
RNase A and BS-RNase. If we use the complex of RNase A with
2-deoxycytidylyl(3–5)-2deoxyadenosine (dCpdA) (61) as a
reference structure, after superimposition of the V1 arm of
ONC with that of the pancreatic enzyme (r.m.s.d.  0.51 Å)
(Fig. 5B), the distances of the nitrogen and oxygen atoms of
Thr35 with N-3C and O-2C atoms of dCpdA are 3.6 and 3.7 Å,
respectively. These values are significantly larger than those of
the corresponding distances in the complex of the pancreatic
enzyme (2.8 and 2.6 Å, respectively) where these hydrogen
bonding interactions substantially contribute to the stability of
the complex. After the superimposition of V1, the best super-
imposition of V2 requires a further rotation of 5.6°, which
decreases the r.m.s.d. between the two V2 arms from 1.54 to
0.55 Å. Very similar figures are found when the complex of
BS-RNase with uridylyl(2,5)adenosine (62) is used as a
comparison.
This geometric analysis suggests that an efficient binding of
the substrate to ONC should require a closure of the two arms
similar to the -sheet breathing motion of RNase A. However,
this kind of motion does not appear to be a feature of the
Onconase dynamic behavior. Thus, the larger active site cleft,
coupled to the unusual low flexibility and in particular to the
absence of the breathing motion of the -sheet, seems to pro-
vide a rationale for the low affinity of ONC for its substrate (23)
and may be crucial in determining its low catalytic activity.
MD Simulations of (C87S,des103–104)-ONC—Molecular dy-
namic simulations have been carried out at 300 K for the
mutant (C87S,des103–104)-ONC too. The results show a strict
similarity with the dynamic behavior of the native protein.
Indeed the root mean square deviations of the C atoms from
the corresponding x-ray structures (2.2 Å) are comparable in
the two cases as indeed are the local motions (Fig. 6). Only
minor differences can be detected for residues 25–29, which are
more mobile in the wild type enzyme, and for residues 72, 73,
and 102 that are more flexible in (C87S,des103–104)-ONC.
Similarly global motions of the two proteins are analogous as
judged by the high RMSIP value (0.70; see “Experimental Pro-
cedures” for details) and by the fact that they have the same
value of the trace of the covariance matrix (0.62 nm2).
In conclusion, ONC and (C87S,des103–104)-ONC exhibit al-
most identical structures and identical dynamic behavior on
the ps/ns time scale at 300 K. These findings demonstrate that
the (C87S,des103–104)-ONC is as rigid as ONC and that the
low flexibility of the amphibian enzyme cannot be related to the
presence of the C-terminal disulfide bridge. On the other hand,
the two proteins do show a marked difference in thermal sta-
bility and do show a different behavior when the MD simula-
tions were performed at higher temperature.
MD Simulations at 350 K—MD simulations have been car-
ried out at 350 K for both ONC and (C87S,des103–104)-ONC.
High temperature simulations have been increasingly per-
formed in the last few years to detect the first steps of the
unfolding pathway of proteins (65, 66) and to address features
of protein thermal stability (59, 60, 67). At this temperature the
root mean square deviations of the C atoms from the starting
FIG. 6. Root mean square (RMS) fluctuations of C atoms in
the equilibrated region of the trajectory for ONC (●) and
(C87S,des103–104)-ONC (Œ) at 300 K.
FIG. 7. Projection of the C atom trajectory along the first two eigenvectors derived from the essential dynamic analysis for ONC
(A) and (C87S,des103–104)-ONC (B) at 350 K. 2D, two-dimensional.
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x-ray structures for (C87S,des103–104)-ONC are significantly
higher than the value obtained for ONC at the same tempera-
ture (3.2 versus 2.2 Å). The traces of the covariance matrices
are also different (1.20 versus 0.79 nm2), supporting the con-
clusion that the higher temperature of the simulation is suffi-
cient to alter the amplitude of the fluctuations in
(C87S,des103–104)-ONC but not in ONC. Indeed the main
difference between the two proteins, as revealed by the simu-
lations, is the finding that ONC samples similar essential
subspaces at 300 and 350 K (RMSIP, 0.69), whereas the con-
formational subspaces sampled by (C87S,des103–104)-ONC at
the studied temperatures are much less overlapped (RMSIP,
0.55). Interestingly similar results were obtained when com-
paring the dynamics of the hyperthermophilic protein Sso7d
and its truncated and less stable variant at two different tem-
peratures (59). To show the dynamic differences between ONC
and (C87S,des103–104)-ONC at 350 K in terms of conforma-
tional space sampling, the projection of the C atom trajectory
along the first two eigenvectors derived from the essential
dynamic analysis for ONC and (C87S,des103–104)-ONC is re-
ported in Fig. 7, A and B. The figure clearly shows that at 350
K (C87S,des103–104)-ONC samples a larger conformational
space compared with ONC. This difference is clearly triggered
by the absence of the C-terminal disulfide bridge, and its re-
duced thermal stability compared with ONC has to be attrib-
uted to the greatly increased number of conformations accessi-
ble to the unfolded state.
CONCLUSIONS
Our present and previous (17, 45) results clearly indicate two
distinctive features of Onconase with respect to other ribo-
nucleases: very small flexibility and very high thermal stabil-
ity, both unusual properties for a mesophilic enzyme. The two
properties are mainly governed by different structural fea-
tures. Rigidity is in principle related to small (harmonic)
atomic positional displacements close to the equilibrium con-
formation and is controlled by the second derivative at the
equilibrium position of the potential constraining the equilib-
rium structure. By contrast the energetic features of larger
anharmonic displacements must play an important role in de-
termining the resistance of the molecule to unfold.
In Onconase the molecular features controlling these two
properties of the enzyme are in a first place orthogonal. Struc-
tural and dynamic properties of (C87S,des103–104)-ONC
clearly indicate that the loss of the C-terminal disulfide bridge
does not affect the rigidity of the enzyme; however, it dramat-
ically reduces the protein thermal stability by increasing the
conformational space accessible to the protein at high temper-
ature as suggested by the 350 K MD simulations. By contrast,
the origin of the low flexibility of the -sheet region of ONC is
probably connected to the reduced length of the loops between
the secondary structure elements. In this respect, the enzyme
can be considered an essential ribonuclease that maintains
intact the regular structure regions of the ribonuclease folding
but has reduced at minimum all the exposed connecting loops.
This feature can be effective in forcing the V-shaped -sheet to
adopt a more opened structure with respect to RNase A. Thus,
the larger cleft coupled with the unusually low flexibility of the
-sheet region may be at the origin of the low affinity of the
enzyme for the substrate (23) and of the low ribonucleolytic
activity. Interestingly all amphibian ribonucleases (RC-RNase
2, RC-RNase 4, and ONC) that lack the loop following the
second helix in RNases (residues 35–40 in RNase A) show very
low catalytic activity comparable to that of ONC. In a rigid
enzyme, as ONC is, the induced fit can be partially inhibited,
and therefore, significant alterations of the function can be
obtained even by very subtle variations of the side chains of
catalytically important residues. In this respect the M23L-
ONC mutant is highly emblematic: the mutation produces a
slight modification of the catalytic residue Lys31, and this less
than 1.0-Å change (68) in the position of N can well account for
the significant increase of the mutant catalytic activity. The
finding that for Onconase very small changes significantly
perturb the catalytic activity can be used to obtain a fine tuning
of ONC properties and improved antitumor drugs.
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